NCT05610436

Brief Summary

The aim of our cohort is to collect prospectively, in a standardized and exhaustive manner, the health data of patients referred to the CAPCoV, our holistic referal post covid clinics for post-covid condition in order to be able to identify typical profiles of patients suffering from post covid syndrome and to follow the evolution of their disease over time.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
500

participants targeted

Target at P75+ for all trials

Timeline
1mo left

Started Jan 2022

Longer than P75 for all trials

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress99%
Jan 2022Jun 2026

Study Start

First participant enrolled

January 7, 2022

Completed
10 months until next milestone

First Submitted

Initial submission to the registry

October 20, 2022

Completed
20 days until next milestone

First Posted

Study publicly available on registry

November 9, 2022

Completed
3.1 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2025

Completed
6 months until next milestone

Study Completion

Last participant's last visit for all outcomes

June 1, 2026

Expected
Last Updated

November 9, 2022

Status Verified

October 1, 2022

Enrollment Period

3.9 years

First QC Date

October 20, 2022

Last Update Submit

November 8, 2022

Conditions

Outcome Measures

Primary Outcomes (1)

  • Symptoms

    Symptoms collected in a standardized manner during consultations, their persistence over time, their evolution (improvement, stagnation, worsening) and their severity (mild, moderate, severe)

    every 6 months up to 3 years

Secondary Outcomes (6)

  • Medical history

    baseline

  • fatigue

    every 6 months up to 3 years

  • Dyspnea

    every 6 months up to 3 years

  • Cognitive impairement

    every 6 months up to 3 years

  • inappropriate hyperventilation syndrome

    every 6 months up to 3 years

  • +1 more secondary outcomes

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

outpatients treated in the Nancy University Hospital Long Covid Support and Care Center for post-Covid condition according to WHO definition

You may qualify if:

  • outpatients treated in the Nancy University Hospital Long Covid Support and Care Center for post-Covid condition according to WHO definition

You may not qualify if:

  • patient opposing the processing for research purposes of their data collected in routine care for their care

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Nancy University Hospital

Vandœuvre-lès-Nancy, Grand Est, 54511, France

RECRUITING

MeSH Terms

Conditions

Post-Acute COVID-19 Syndrome

Condition Hierarchy (Ancestors)

COVID-19Pneumonia, ViralPneumoniaRespiratory Tract InfectionsInfectionsVirus DiseasesCoronavirus InfectionsCoronaviridae InfectionsNidovirales InfectionsRNA Virus InfectionsLung DiseasesRespiratory Tract DiseasesPost-Infectious DisordersChronic DiseaseDisease AttributesPathologic ProcessesPathological Conditions, Signs and Symptoms

Study Officials

  • Francois GOEHRINGER, MD

    Infectious Diseases Department, Nancy University Hospital,F-54000 Nancy, France.

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Francois GOEHRINGER, MD

CONTACT

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator, clinical physician, Infectious Diseases department

Study Record Dates

First Submitted

October 20, 2022

First Posted

November 9, 2022

Study Start

January 7, 2022

Primary Completion

December 1, 2025

Study Completion (Estimated)

June 1, 2026

Last Updated

November 9, 2022

Record last verified: 2022-10

Locations